InMed Pharmaceuticals Inc (NASDAQ:INM)

Delayed Data
As of 4:00pm ET
 -0.02 / -1.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for InMed Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +1,023.60% increase from the last price of 1.78.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in InMed Pharmaceuticals Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.84%
Growthannually 52.01%


Growthquarterly 55.87%
Growthannually 835.44%
Key to the earnings and sales forecast charts.